Overview
- Foundation stone laid for ICHOR Biologics’ new Genome Valley facility to expand the state’s life sciences infrastructure.
- Government has offered incentives and fast-track approvals to investors in sectors including pharma, electric vehicles and IT to secure Rs 3.28 lakh crore.
- Telangana is marketing itself as a China Plus One alternative by strengthening infrastructure and policy stability for global manufacturers.
- Hyderabad’s Genome Valley now produces about one-third of India’s vaccines and 43 percent of its bulk drugs, reaffirming its R&D leadership.
- The Telangana Rising 2047 vision document will be released on December 9, 2025, outlining steps to reach a $1 trillion economy by 2035 and $3 trillion by 2047.